Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Acadia Healthcare Company (ACHC) EBIT (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed EBIT for 16 consecutive years, with -$1.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, EBIT fell 642.11% to -$1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.6 billion, a 619.52% decrease, with the full-year FY2025 number at -$223.8 million, down 197.68% from a year prior.
  • EBIT was -$1.3 billion for Q4 2025 at Acadia Healthcare Company, down from -$280.3 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $248.2 million in Q4 2024 to a low of -$1.3 billion in Q4 2025.
  • A 5-year average of -$79.3 million and a median of $4.3 million in 2022 define the central range for EBIT.
  • Peak YoY movement for EBIT: soared 1066.82% in 2022, then plummeted 4927.3% in 2023.
  • Acadia Healthcare Company's EBIT stood at $17.1 million in 2021, then crashed by 824.2% to -$123.5 million in 2022, then surged by 143.15% to $53.3 million in 2023, then soared by 365.79% to $248.2 million in 2024, then plummeted by 642.11% to -$1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ACHC's EBIT are -$1.3 billion (Q4 2025), -$280.3 million (Q3 2025), and $21.5 million (Q2 2025).